HK1205679A1 - Nicotine formulation - Google Patents

Nicotine formulation

Info

Publication number
HK1205679A1
HK1205679A1 HK15106184.6A HK15106184A HK1205679A1 HK 1205679 A1 HK1205679 A1 HK 1205679A1 HK 15106184 A HK15106184 A HK 15106184A HK 1205679 A1 HK1205679 A1 HK 1205679A1
Authority
HK
Hong Kong
Prior art keywords
nicotine formulation
nicotine
formulation
Prior art date
Application number
HK15106184.6A
Other languages
English (en)
Chinese (zh)
Inventor
Fredrik Hbinette
Original Assignee
Nicoccino Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoccino Ab filed Critical Nicoccino Ab
Publication of HK1205679A1 publication Critical patent/HK1205679A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
HK15106184.6A 2012-03-27 2015-06-30 Nicotine formulation HK1205679A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261615997P 2012-03-27 2012-03-27
EP12161483 2012-03-27
PCT/EP2013/055456 WO2013143891A1 (en) 2012-03-27 2013-03-15 Nicotine formulation

Publications (1)

Publication Number Publication Date
HK1205679A1 true HK1205679A1 (en) 2015-12-24

Family

ID=49258262

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106184.6A HK1205679A1 (en) 2012-03-27 2015-06-30 Nicotine formulation

Country Status (21)

Country Link
US (1) US20150096572A1 (ko)
EP (1) EP2830589B1 (ko)
JP (2) JP6412492B2 (ko)
KR (1) KR102038342B1 (ko)
CN (1) CN104411297B (ko)
AU (1) AU2013242200B2 (ko)
BR (1) BR112014023823B1 (ko)
CA (1) CA2868445C (ko)
HK (1) HK1205679A1 (ko)
IN (1) IN2014DN08879A (ko)
MX (1) MX362918B (ko)
MY (1) MY183216A (ko)
NZ (1) NZ626974A (ko)
PL (1) PL2830589T3 (ko)
RS (1) RS58677B1 (ko)
RU (1) RU2625836C2 (ko)
SG (1) SG11201405958RA (ko)
SI (1) SI2830589T1 (ko)
UA (1) UA116440C2 (ko)
WO (1) WO2013143891A1 (ko)
ZA (1) ZA201407677B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3166563T3 (da) * 2014-07-08 2021-02-15 Fertin Pharma As Oralt administrationssystem omfattende to rum
US20200085806A1 (en) * 2016-12-20 2020-03-19 Fertin Pharma A/S A mucoadhesive oromucosal formulation comprising a nicotine complex
WO2020136062A1 (en) * 2018-12-28 2020-07-02 Philip Morris Products S.A. Nicotine formulation comprising metal salt
JP2022516149A (ja) * 2018-12-31 2022-02-24 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 液体ニコチン製剤
SE544672C2 (en) * 2020-05-07 2022-10-11 Liw Innovation Ab New compositions for oral or nasal use
WO2024037043A1 (zh) * 2023-04-28 2024-02-22 深圳华宝协同创新技术研究院有限公司 用于口腔粘膜的包含尼古丁的薄膜组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86170A (en) 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
CA2178021C (en) * 1996-04-19 1999-09-28 Theodore H. Stanley Tobacco substitute
SE9900215D0 (sv) 1999-01-26 1999-01-26 Pharmacia & Upjohn Ab New use
JP5089840B2 (ja) * 2001-09-25 2012-12-05 救急薬品工業株式会社 ニコチン含有フィルム製剤
GB0508306D0 (en) 2005-04-25 2005-06-01 Bioprogress Technology Ltd Nicotine dosage forms
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
US20080286341A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
SG187480A1 (en) * 2007-10-11 2013-02-28 Philip Morris Prod Smokeless tobacco product
CN101896172A (zh) * 2007-12-11 2010-11-24 诺瓦提斯公司 多区膜
HUE038093T2 (hu) * 2009-03-13 2018-09-28 Excellent Tech Products I Sverige Ab Orális bejuttatású termék

Also Published As

Publication number Publication date
MY183216A (en) 2021-02-18
KR102038342B1 (ko) 2019-10-30
NZ626974A (en) 2016-09-30
RU2014143003A (ru) 2016-05-20
KR20140140021A (ko) 2014-12-08
US20150096572A1 (en) 2015-04-09
ZA201407677B (en) 2016-05-25
MX362918B (es) 2019-02-26
EP2830589B1 (en) 2019-02-13
WO2013143891A1 (en) 2013-10-03
CN104411297A (zh) 2015-03-11
MX2014010760A (es) 2015-03-20
JP6412492B2 (ja) 2018-10-24
EP2830589A1 (en) 2015-02-04
JP2015516948A (ja) 2015-06-18
IN2014DN08879A (ko) 2015-05-22
AU2013242200A1 (en) 2014-10-16
RS58677B1 (sr) 2019-06-28
JP2017226686A (ja) 2017-12-28
CN104411297B (zh) 2017-10-24
PL2830589T3 (pl) 2019-07-31
CA2868445C (en) 2020-01-28
BR112014023823A2 (ko) 2017-06-20
SI2830589T1 (sl) 2019-06-28
BR112014023823B1 (pt) 2022-04-26
RU2625836C2 (ru) 2017-07-19
CA2868445A1 (en) 2013-10-03
SG11201405958RA (en) 2014-10-30
UA116440C2 (uk) 2018-03-26
AU2013242200B2 (en) 2017-03-02

Similar Documents

Publication Publication Date Title
HK1211188A1 (en) Nicotine composition
PL2877155T3 (pl) Formulacje opioidowe
EP2932860A4 (en) CIGARETTE
HK1202445A1 (en) New formulation
ZA201306000B (en) Stable formulation
HK1205679A1 (en) Nicotine formulation
IL289157A (en) Opioid compounds
PL2908835T3 (pl) Stabilne formulacje
EP2856890A4 (en) CIGARETTE
EP2818060A4 (en) CIGARETTE
AU345796S (en) Cigarette
AU345797S (en) Cigarette
HK1207290A1 (en) Oral formulation
PL2908859T3 (pl) Formulacje arypiprazolu
IL234771A0 (en) Nicotine formulation
GB201211247D0 (en) Improved formulation
GB201206178D0 (en) Formulations
AU345795S (en) Cigarette
AU345910S (en) Cigarette